Pharmaceutical manufacturers of Famotidine

Minakem is a fully integrated commercial manufacturer of Active Pharmaceutical Ingredients (APIs) with R&D capabilities to develop and transfer the manufacturing process to one of its four API facilities in Europe or Canada

For more than 40 years, Apotex has been a reputable name in the Canadian pharmaceutical industry, offering patients increased availability to high-quality, cost-effective medications

Alembic Pharmaceuticals Limited is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat, we derive a third of our revenue of over $600 million from the India market.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has Fifteen API and Six finished dosage facilities established across India & USA. The group has an integrated R&D center for both API and formulation under one roof, dedicated to research and development of pharmaceuticals to make them more accessible.

The Zydus group is based in Ahmedabad, India, and is placed 4th in the Indian pharmaceutical sector. Zydus' global operations have a substantial presence in the regulated markets of the US, Europe (specifically France and Spain), and in the prominent markets of Latin America and South Africa. It also has a significant presence in 25 other developing markets around the world.

Established in the year 1987, Nakoda Chemicals Pvt. Ltd. is distinctively positioned ourselves as one of the renowned wholesalers, supplier, importer and traders of a quality approved range of Industrial and Agro Chemicals. Some of our offered products are Ammonium Bicarbonate, Ammonium Sulphate and Ammonium Chloride. Our provided products are formulated by using quality assured chemical compounds and contemporary technology. Our offered product range is highly demanded for its enhanced shelf life, precise pH value, precise composition and effective usage. These chemicals are cherished by our clients for their safe usage and for offering optimum results. Our products are procured from the authorized vendors, possessing huge experience in this domain. Furthermore, our trained professionals stringently inspect the products’ quality on different quality testing parameters at the time of procuring from the vendors till the final packaging of consignment. We make sure that the offered products are processed in a hygienic atmosphere so as to comply with the set standards of industry. We import our product from China.

Wockhardt UK (WUK) operates as a diverse pharmaceutical company, serving as a significant provider of healthcare products to the NHS through hospitals, multiple retail pharmacy chains, and wholesalers. It is currently experiencing an exciting period with thriving export and contract manufacturing divisions. Leveraging the global strength, research base, and impressive product pipeline of its parent company, Wockhardt UK is well-positioned for future growth.

Rakshit Corporation, has a long-standing presence in the field of API production, operating for more than 20 years and possessing facilities that are sanctioned by USFDA, Japan-PMDA, Korean FDA, and multiple approved CEPs. Rakshit stands as the primary global producer of Sildenafil Citrate API and its intermediates, specializing in the production of Erectile Dysfunction APIs. The Rakshit conglomerate is equipped with three manufacturing units that comply with cGMP standards.

Bringing 86 years of expertise, UQUIFA'S operational approach is built on a fusion of a high-quality production platform and a proven history of service and dependability. UQUIFA specializes in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and RSM's for the pharmaceutical and animal health sectors on a global scale. The organization runs 2 production facilities (located in Spain and Mexico) with stringent compliance to all regulatory standards. These facilities operate under cGMP conditions and have undergone evaluation and endorsement from prominent global pharmaceutical companies.

Dr. Reddy’s Laboratories Ltd. functions as an integrated pharmaceutical firm, dedicated to supplying cost-effective and innovative medications to promote healthier lifestyles. With a focus on Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products, Dr. Reddy’s delivers a range of products and services such as APIs, customized pharmaceutical services, generics, biosimilars, and distinct formulations. The primary therapeutic areas of concentration encompass gastro-intestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s has a presence in various global markets, with significant engagements in the USA, Europe, India, Russia, and other CIS nations.

We are one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. We endeavour to serve patients by moulding science and technology into therapies to improve health outcomes and people’s lives.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

SMS Lifesciences India Limited, headquartered in Hyderabad, India, is a research-driven company with over three decades of experience. It is a public listed leading API manufacturer, supplying to major generic and innovator firms. With a focus on APIs, the company operates four state-of-the-art facilities and provides quality alternative manufacturing solutions to multinational companies for their contract research and manufacturing needs. The company has multiple manufacturing facilities supporting a wide range and capacity of APIs and Intermediates.

Astellas Pharma Inc. is dedicated to realizing its corporate mission of enhancing global health by developing and delivering innovative and dependable pharmaceutical products. The company is committed to supporting patients worldwide by continually producing groundbreaking and highly effective medications for diseases with significant unmet medical needs through its research and development endeavors.

Azico Biophore India Pvt. Ltd. operates a facility for manufacturing active pharmaceutical ingredients (APIs) which has undergone successful inspections by the US FDA on three occasions, with the most recent audit conducted in February 2019. The company holds 22 active Drug Master Files (DMFs). They offer a Customized Business Model, providing supplies from conceptualization to commercialization, as well as contract manufacturing of APIs, Key Starting Materials (KSMs), and Intermediates.

Established in 1993, SUANFARMA is a business-to-business partner in the field of life sciences specializing in the formulation, manufacture, and marketing of components for the pharmaceutical, veterinary, and nutraceutical sectors. In SUANFARMA, we provide our CDMO capabilities for fermentation and chemical synthesis projects, delivering a comprehensive service with a proven track record, facilitating success in the formulation, expansion, production, and marketing of an API, whether it is innovative or generic

Kekule Pharma Limited was established in 1984 and sanctioned by USFDA. We are prominent producers of Advanced intermediates and Active Pharmaceutical Ingredients (API) and also specialize in the creation of groundbreaking procedures for the union of a vast array of products. Our establishment has been scrutinized by various multinational companies and we distribute our APIs and Advanced intermediates to numerous nations. Recently, our facility underwent an examination by MFDS, and we have submitted our findings

YungShin commenced its operations in 1952 and by 1978, it had also formed global subsidiaries such as Yung Zip Chemical in Taiwan, CTI in the US, YSP Southeast Asia, and YSP China. YungShin specializes in the development and manufacturing of finished products and APIs. The company also maintains stringent adherence to advanced ERP system, SAP, SOPs, and meticulous compliance with PIC/S GMP, Japanese MHLW, and US FDA regulations. YungShin offers comprehensive drug development and contract manufacturing services from its facilities in Taiwan.